Drug resistance phenotype

Aliases

ability to say no, resistance to drugs

No related entities found.

Mentioned in (22)

Papers in which this entity is mentioned.

• Multigenerational cell tracking of DNA replication and heritable DNA damage. (2025)
• Chromosomal instability as a driver of cancer progression. (2025)
• Splicing neoantigen discovery with SNAF reveals shared targets for cancer immunotherapy. (2024)
• Synthetic augmentation of cancer cell line multi-omic datasets using unsupervised deep learning. (2024)
• Towards understandings of serine/arginine-rich splicing factors. (2023)
• RNA splicing dysregulation and the hallmarks of cancer. (2023)
• Application of third-generation sequencing in cancer research. (2021)
• A practical guide to cancer subclonal reconstruction from DNA sequencing. (2021)
• Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes. (2021)
• Emerging Roles of SRSF3 as a Therapeutic Target for Cancer. (2020)
• Super-enhancers: critical roles and therapeutic targets in hematologic malignancies. (2019)
• The Clonal Evolution of Metastatic Osteosarcoma as Shaped by Cisplatin Treatment. (2019)
• Evidence-based design and evaluation of a whole genome sequencing clinical report for the reference microbiology laboratory. (2018)
• Sensitivity to sequencing depth in single-cell cancer genomics. (2018)
• ClonEvol: clonal ordering and visualization in cancer sequencing. (2017)
• Unraveling the clonal hierarchy of somatic genomic aberrations. (2014)
• Involvement of p53 in the repair of DNA double strand breaks: multifaceted Roles of p53 in homologous recombination repair (HRR) and non-homologous end joining (NHEJ). (2014)
• A comparative analysis of algorithms for somatic SNV detection in cancer. (2013)
• Differential expression profiles of glycosphingolipids in human breast cancer stem cells vs. cancer non-stem cells. (2013)
• Integrative analysis reveals relationships of genetic and epigenetic alterations in osteosarcoma. (2012)
• Ultrasensitive detection of rare mutations using next-generation targeted resequencing. (2012)
• Patient-derived tumour xenografts as models for oncology drug development. (2012)

Merged raw entities (3)

All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.